Moxifloxacin-8-chloro | Interleukin Related interleukin-related.com

Product Name :
Moxifloxacin-8-chloro

Search keywords :
BAY-Y 3118

drugId :
null

Target Vo:
Topoisomerase II

Target Vo Short Name :
TOP2

Moa_Name:
Topoisomerase II inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bayer AG

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Bacterial Infections

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RHEB Rabbit mAb Epigenetics
STAT3 Rabbit mAb Technical Information
PPP4C Antibody (YA687): PPP4C Antibody (YA687) is a non-conjugated and Mouse origined monoclonal antibody about 35 kDa, targeting to PPP4C (2F11). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts